Anna Turetsky
InvestorGeneral Partner, PxB Fund at OUP (Osage University Partners)
New York, New York, United States
Find your path to Anna
805 people in our graph share verified history with Anna — schools, employers, funds. One of them is your warm intro.
Crystal HuangunlockedAnna: together at Harvard University (2009–2011)
×5Anna: together at University of Pennsylvania
×2Anna: together at Harvard University
×4Anna: together at Center for Systems Biology, Massachusetts General Hospital
About
Anna Turetsky joined OUP in 2025 as General Partner of the $50M PxB Fund (Penn-BioNTech Innovative Therapeutics Seed Fund), focusing exclusively on life science companies emerging from University of Pennsylvania technologies. She previously launched and led the venture investing arm of the Mark Foundation for Cancer Research and began her career at Lightstone Ventures. She holds a Ph.D. in Biophysics from Harvard University and a B.A. in Biochemistry from the University of Pennsylvania.
Invests in
Biotech
Experience
- Osage University Partners (OUP)General Partner, PxB Fundcurrent2025 — present
- Verseau TherapeuticsBoard Membercurrent2019 — present
- Pommette, LLCStrategy, BD, and Corporate Development2024 — 2026New York, New York, United States
- Hyku BiosciencesBoard Observer2023 — 2024Greater Boston
- Vicinitas TherapeuticsBoard Observer2022 — 2024South San Francisco, California, United States
- Immunitas TherapeuticsBoard Observer2021 — 2024Greater Boston
- Interius BioTherapeuticsBoard Observer2020 — 2024Philadelphia, Pennsylvania, United States
- Accent Therapeutics, Inc.Board Observer2020 — 2024Greater Boston
- The Mark Foundation for Cancer ResearchPrincipal, Venture Investments2019 — 2024New York, New York, United States
- C2i GenomicsBoard Observer2020 — 2024New York, New York, United States
- Cyteir TherapeuticsBoard Observer2018 — 2019Greater Boston Area
- Locana, Inc.Board Observer2017 — 2019Greater San Diego Area
- Disarm TherapeuticsBoard Observer2017 — 2019Greater Boston Area
- Lightstone VenturesVice President2017 — 2019Boston, Massachusetts, United States
- Lightstone VenturesAssociate2015 — 2017Boston, Massachusetts, United States
- Gemini TherapeuticsBoard Observer2016 — 2019Greater Boston Area
- Tizona Therapeutics, Inc.Board Observer2016 — 2019San Francisco Bay Area
- Hydra BiosciencesBoard Observer2015 — 2019Greater Boston Area
- Fletcher Spaght, Inc.Analyst, Healthcare Consulting2014 — 2015Greater Boston Area
- Center for Systems Biology, Massachusetts General HospitalNSF Graduate Research Fellow2010 — 2014Greater Boston Area
- Innotrove LLCConsultant2013Greater Boston Area
- Harvard GSAS Business ClubCo-President2012 — 2013Greater Boston Area
- Harvard GSAS Business ClubFounding Board Member & Co-Director of Career Development2011 — 2012Greater Boston Area
- Siemens Venture CapitalCorporate Venture Capital Intern2013Greater Boston Area
- Harvard Office of Technology DevelopmentEarly Technology Assessment Fellow2012 — 2013Greater Boston Area
Investments
Board seats
Verseau Therapeutics
Investor
Accent TherapeuticsC2i GenomicsHyku BiosciencesImmunitas TherapeuticsInterius BioTherapeuticsVicinitas Therapeutics
Per the firm's website.
Colleagues at OUP (Osage University Partners)
Ajay Rayasam
Principal at Osage University Partners
Allen Chen
Principal at Osage University Partners
Beth Grafstrom
Senior Vice President at OUP (Osage University Partners)
Britt Kennett
Senior Executive Assistant at OUP (Osage University Partners)
Brittany de Kouchkovsky
Director, University Relations at Osage University Partners
Chris Nawalinski
Fund Accountant at OUP (Osage University Partners)
Claudia Dunnous
Chief Financial Officer at OUP (Osage University Partners)
David R. Williams
Director at 50 South Capital
Frequently asked questions
- Who is Anna Turetsky?
- Anna Turetsky joined OUP in 2025 as General Partner of the $50M PxB Fund (Penn-BioNTech Innovative Therapeutics Seed Fund), focusing exclusively on life science companies emerging from University of Pennsylvania technologies. She previously launched and led the venture investing arm of the Mark Foundation for Cancer Research and began her career at Lightstone Ventures. She holds a Ph.D. in Biophysics from Harvard University and a B.A. in Biochemistry from the University of Pennsylvania.
- Where does Anna Turetsky work?
- Anna Turetsky is General Partner, PxB Fund at OUP (Osage University Partners).
- What does Anna Turetsky invest in?
- Anna Turetsky invests in Biotech.
- What boards does Anna Turetsky sit on?
- Anna Turetsky holds tracked board seats at Verseau Therapeutics.
- What companies has Anna Turetsky invested in?
- Investments tracked here include Accent Therapeutics, C2i Genomics, Hyku Biosciences, Immunitas Therapeutics, Interius BioTherapeutics, Vicinitas Therapeutics.
- Where did Anna Turetsky go to school?
- Anna Turetsky studied at Harvard University (PhD, Biophysics); University of Pennsylvania (BA, Biochemistry (major); Fine Arts).
Same school
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Also attended University of Pennsylvania1,233
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 1,227 more
Shared employers
Also worked at Verseau Therapeutics3
Also worked at Accent Therapeutics, Inc.4
Also worked at Locana, Inc.1
Also worked at Lightstone Ventures18
Adam BrucePartner, Chief Financial and Chief Operating Officer at Flare Capital PartnersMike CarusiManaging Partner at Lightstone VenturesCaroline GaynorPartner at Lightstone VenturesHanson S. Gifford, IIIPartner at Lightstone VenturesMark DeemOperating Partner at Lightstone VenturesOlivia PeterVice President, Finance at Lightstone Ventures
+ 12 more